Bronchial asthma: simple solutions of complex issues
The problem of achieving control of bronchial asthma (BA), regardless of severity, remains relevant. The use of extra-finely dispersed Beclomethasone/Formoterol FC (EMB FC BDP/FOR) according to the concept of Maintenance and Reliever Therapy (MART) has clinical advantages over traditional basal ther...
Main Authors: | I. V. Leshchenko, I. I. Baranova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2976 |
Similar Items
-
Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01) -
BRONCHIAL ASTHMA THERAPY IN SMART-REGIME: STUDIES IN REAL CLINICAL PRACTICE
by: R. S. FASSAKHOV
Published: (2016-12-01) -
NEW POSSIBILITIES OF MILD BRONCHIAL ASTHMA THERAPY
by: N. M. NENASHEVA
Published: (2016-12-01) -
Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01) -
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial
by: Papi Alberto, et al.
Published: (2012-06-01)